FDA OKs rare neurologic disease treatment
Monday, September 15, 2008 - 09:49
in Health & Medicine
WASHINGTON, Sept. 15 (UPI) -- The U.S. Food and Drug Administration approved an immune globulin product called Gamunex for treatment of chronic inflammatory demyelinating polyneuropathy.
Read the whole article
See latest science articles from UPI
Latest Science Newsletter
Get the latest and most popular science news articles of the week in your Inbox!Related
- Key protein molecule linked to diverse human chronic inflammatory diseasesMon, 15 Sep 2008, 16:09:25 EDT
- Personalized therapy for asthma and COPD could soon be hereSun, 18 May 2008, 14:28:28 EDT
- Bugs in the gut trigger production of important immune cells, NYU study findsWed, 15 Oct 2008, 18:08:23 EDT
- Biodegradable polymers show promise for improving treatment of acute inflammatory diseasesWed, 20 Aug 2008, 12:21:49 EDT
- Previously unknown immune cell may help those with Crohn's and colitisMon, 3 Nov 2008, 16:11:23 EST